Anixa Biosciences, Inc. (ANIX)
3.07
+0.02
(+0.66%)
USD |
NASDAQ |
Sep 04, 16:00
3.07
0.00 (0.00%)
After-Hours: 20:00
Anixa Biosciences SG&A Expense (TTM) : 6.118M for April 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| April 30, 2026 | 6.118M |
| January 31, 2026 | 6.41M |
| October 31, 2025 | 6.63M |
| July 31, 2025 | 6.583M |
| April 30, 2025 | 6.869M |
| January 31, 2025 | 7.009M |
| October 31, 2024 | 7.435M |
| July 31, 2024 | 7.184M |
| April 30, 2024 | 7.273M |
| January 31, 2024 | 7.063M |
| October 31, 2023 | 6.291M |
| July 31, 2023 | 6.779M |
| April 30, 2023 | 6.375M |
| January 31, 2023 | 6.618M |
| October 31, 2022 | 7.172M |
| July 31, 2022 | 7.152M |
| April 30, 2022 | 8.021M |
| January 31, 2022 | 7.582M |
| October 31, 2021 | 7.074M |
| July 31, 2021 | 7.004M |
| April 30, 2021 | 5.964M |
| January 31, 2021 | 5.991M |
| October 31, 2020 | 5.597M |
| July 31, 2020 | 5.020M |
| April 30, 2020 | 4.895M |
| Date | Value |
|---|---|
| January 31, 2020 | 4.736M |
| October 31, 2019 | 5.663M |
| July 31, 2019 | 6.715M |
| April 30, 2019 | 8.361M |
| January 31, 2019 | 7.988M |
| October 31, 2018 | 6.912M |
| July 31, 2018 | 5.946M |
| April 30, 2018 | 4.750M |
| January 31, 2018 | 4.541M |
| October 31, 2017 | 4.411M |
| July 31, 2017 | 3.067M |
| April 30, 2017 | 2.482M |
| January 31, 2017 | 2.835M |
| October 31, 2016 | 3.306M |
| July 31, 2016 | 4.380M |
| April 30, 2016 | 4.879M |
| January 31, 2016 | 5.784M |
| October 31, 2015 | 6.226M |
| July 31, 2015 | 6.754M |
| April 30, 2015 | 6.434M |
| January 31, 2015 | 6.321M |
| October 31, 2014 | 6.479M |
| July 31, 2014 | 6.75M |
| April 30, 2014 | 7.866M |
| January 31, 2014 | 7.874M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 172.57M |
| Oncolytics Biotech, Inc. | 16.62M |
| Sangamo Therapeutics, Inc. | 31.64M |
| Sarepta Therapeutics, Inc. | 436.74M |
| Vicapsys Life Sciences, Inc. | -0.0004M |